Stepped Care Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
Completed · Not applicable
Conditions studied: Obsessive Compulsive Disorder, Stepped Care Cognitive Behavioral Therapy
In brief
The purpose of this research study is to determine how well children with OCD can be helped using therapy that requires less clinic visits. The investigators are testing a Stepped-Care Cognitive Behavioral Therapy (SC-CBT) approach in which children receive a full course of parent-led, therapist-guided treatment for OCD. The goal is to see if therapy can be done in fewer visits to the clinic. Children receiving SC-CBT will start with Step One, which includes three therapy sessions over six weeks. Those who do not get better in Step One will "STEP UP" to Step Two which involves coming in to meet with a therapist for the remaining sessions. Youth receiving SC-CBT will be compared to youth receiving standard CBT in the clinic through this study. It is expected that Stepped Care will be an acceptable, cost-effect, and feasible treatment with outcomes similar to standard CBT.
Key facts
- Study ID
- NCT01981317
- Run by
- University of South Florida
- People needed
- 30
- Starts
- 2013-10-01
- Expected to finish
- 2018-10-01
- Last updated by the study team
- 2019-03-20
Who can join
Age: 8 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Outpatient youth with obsessive-compulsive disorder between the ages 8-17 years.
- A Children's Yale-Brown Obsessive-Compulsive Scale score ≥ 16
- Child has a Full Scale IQ ≥ 80 as assessed on the WASI
- English speaking
You may not qualify if…
- Past adequate CBT with E/RP trial
- Initiation of antidepressant medication within 12 weeks before study enrollment, or an antipsychotic/mood stabilizer medication 6 weeks before study enrollment, or a stimulant/anxiolytic or alpha 2 agonist 4 weeks before study enrollment
- Established Treatment changes: Any change in dose of an established psychotropic medication (e.g., antidepressants) within 8 weeks before study enrollment (4 weeks for antipsychotic, mood stabilizer, alpha 2 agonist; 2 weeks for stimulant/anxiolytic). Alternative medications must be stable for 4 weeks prior to baseline. Any medications must remain stable during treatment; downward adjustments due to side effects may be acceptable with PI approval.
- Active child suicidality assessed by all available information (e.g., KSADS-PL, CDI).
- DSM-IV conduct disorder, autism, mental retardation, bipolar, schizophrenia/schizoaffective disorders; or substance abuse in past 6 months; or co-primary eating disorder; using all available information.
- Another behavioral/emotional problem or psychiatric disorder is considered to be more problematic than OCD.
- Non-English speaking.
- WASI-IQ SS <80.
Where it is running
- The Rothman Center for Pediatric Neuropsychiatry — St. Petersburg, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.